Physician profile
Holly L Thacker
NPI 1427013598
$64,697.24
in general payments reported to CMS, 2019-2025
12 companies · $543 in 2025
The $543 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $12K · 2021: $1,800 · 2022: $7,826 · 2023: $748 · 2024: $496 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,391 · Education: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,391.42 |
| Education | $396.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $45,034.56 | 2019-2020 | |
| Astellas Pharma US INC | $13,303.54 | 2019-2025 | Veozah |
| Abbvie INC. | $3,675.00 | 2022 | |
| Scynexis, INC. | $1,113.99 | 2022 | |
| Amgen INC. | $936.75 | 2019-2025 | Evenity, Prolia |
| Mayne Pharma Commercial LLC | $202.24 | 2023-2025 | |
| Radius Health, INC. | $180.09 | 2019 | |
| Merck Sharp & Dohme LLC | $92.85 | 2019 | |
| Alexion Pharmaceuticals, INC. | $81.00 | 2023 | Strensiq |
| Exeltis, USA INC. | $36.96 | 2023-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $20.28 | 2025 | |
| Millicent US INC | $19.98 | 2025 | Femlyv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Thacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.